1
|
\nAzithromycin 10 mg (1% W/W)\n |
Eye Ointment |
5 GM |
2
|
Acyclovir Eye Ointment IP 3%w/w |
Eye Ointment |
5 gm |
3
|
Atropine Sulphate 1%w/w |
Eye Ointment |
|
4
|
Chloramphenicol I.P. 10 mg, Hydrocortisone Acetate I.P. 5 mg (TUBE) |
Eye Ointment |
5 gm |
5
|
Ciprofloxacin 0.3% w/w |
Eye Ointment |
|
6
|
Carboxymethycellulose Sodium 1.0%w/w |
Eye Ointment |
5 gm |
7
|
Hydroxypropyl Methylcellulose 2% w/w |
Eye Ointment |
|
8
|
Moxifloxacin Hydrochloride IP eq. to Moxifloxacin Base 0.5% w/v , Sterlized Parafin Base (TUBE) |
Eye Ointment |
5 GM |
9
|
Sodium Carboxymethycellulose 0.3%w/w,Glycerin 1.0% w/w |
Eye Ointment |
|
10
|
Ganciclovir Ophthalmic Gel 0.15%w/w |
Eye GEL |
5 GM |
11
|
Tacrolimus 0.03% w/w |
Eye Ointment |
|
12
|
Alcaftadine 0.25%w/v |
Eye Drop |
|
13
|
Atropine Sulphate USP 0.01% w/v, Stabilized Oxychloro Complex (as a presevative )0.05% w/v |
Eye Drop |
5 ML |
14
|
Azithromycin 1.0 %w/v |
Eye Drop |
|
15
|
Bepotastine Besilate 15.0 mg, Eq. to Bepotastine 10.7 mg |
Eye Drop |
|
16
|
Besifloxacin 0.6% w/v\n |
Opthalmic Susp. |
|
17
|
Bimatoprost 0.03% w/v, Timolol Maleate 0.5% w/v |
Opthalmic Sol. |
|
18
|
Bimatoprost 0.03% w/v\n |
Opthalmic Sol. |
|
19
|
Brimonidine Tartrate 0.1% w/v |
Opthalmic Sol. |
|
20
|
Brimonidine tartrate 0.15 % w/v and Timolol 0.5 % w/v |
Opthalmic Sol. |
5 ml |
21
|
Brimonidine Tartrate 0.2 %w/v, Timolol 0.5% w/v \n |
Opthalmic Sol. |
5 ML |
22
|
Brimonidine Tartrate 0.2%w/v\n |
Opthalmic Sol. |
|
23
|
Brimonidine Tartrate 0.15%w/v\n |
Opthalmic Sol. |
5 ml |
24
|
Brinzolamide Ophthalmic Suspension 1.0% w/v |
Opthalmic Sol. |
|
25
|
Gatifloxacin 0.3%w/w , Dexamethasone Sodium Phosphate 0.1 %w/w |
Eye Drop |
|
26
|
Gatifloxacin 0.3% w/v & Ketorolac Tromethamine 0.4 % w/v |
Eye Drop |
5 ML |
27
|
Gatifloxacin 0.3% w/v , Benzalkonium Chloride Solution IP 0.02% |
Eye Drop |
5 ml |
28
|
Gatifloxacin 0.3% w/v , Difluprednate 0.05% w/v, Benzalkonium Chloride Solution IP 0.01% |
Eye Drop |
|
29
|
Hydroxypropyl Methyl Cellulose IP 2%w/v\n Sodium Chloride IP 0.49%w/v\nPotassium Chloride IP 0.075%w/v\nCalcium Chloride IP 0.048%w/v\nMagnesium Chloride IP 0.030%w/v\nSodium Acetate IP 0.390%w/v\nSodium Citrate IP 0.170%w/v Water for Injection IP q.s. |
Opthalmic Sol. |
|
30
|
Bromfenac Sodium Eq. to Bromfenac Free Acid 0.09% w/v |
Eye Drop |
5 ml |
31
|
Carbachol 0.01 % w/v |
INTRAOCULAR SOLUTION |
|
32
|
Carboxymethylcellulose Sodium 0.5% w/v |
Eye Drop |
10 ml |
33
|
Carboxymethylcellulose Sodium 0.5% w/v, Stabilized Oxychloro 0.005% w/v |
Eye Drop |
10 ml |
34
|
Carboxymethylcellulose Sodium 1.00% w/v Stabilized Oxychloro 0.005% w/v |
Eye Drop |
10 ml |
35
|
Carboxymethylcellulose Sodium 1.0% w/v\nStabilized Oxychloro Complex 0.0075% w/v |
Eye Drop |
10 ml |
36
|
Carboxymethylcellulose Sodium IP 3 mg N-Acetyl-L-Carnosine 10 mg Glycerin IP 10 mg Stabilized Oxychloro Complex 0.005% w/v |
Eye Drop |
10 ML |
37
|
Carboxymethylcellulose Sodium 0.5% + Stabillized oxy chloro complex 0.01%with other in gredients Glycerine, Erythritol,Levocarnitine, Boric acid, |
Eye Drop |
10 ML |
38
|
Chloramphenicol 0.5% w/v Dexamethasone Sodium Phosphate IP 0.1%w/v Hydroxypropyl Methyl Cellulose IP 0.25% w/v Phenyl mercuric Nitrate 0.002% w/v |
Opthalmic Sol. |
|
39
|
Ciprofloxacin 0.3% w/v & Dexamethasone Sodium Phosphate 0.1% w/v |
Opthalmic Sol. |
10 ML |
40
|
Cyclopentolate 1% |
Eye Drop |
|
41
|
Cyclosporine 0.5 mg |
Eye Drop |
|
42
|
Difluprednate 0.05% & Moxifloxacin Hydrochloride 0.5% |
Eye Drop |
5 ML |
43
|
Difluprednate 0.05% w/v |
Eye Drop |
5 ml |
44
|
Dorzolamide Hydrochloride 2% w/v\n |
Eye Drop |
10 ML |
45
|
D-Panthenol 5%w/v & Sodium Hyaluronate 0.1 % w/v |
Opthalmic Sol. |
|
46
|
Fluconazole 0.3 % |
Eye Drop |
5 ml |
47
|
Fluorometholone Ophthalmic Suspension 0.1%w/v |
Opthalmic Sus. |
5 ml |
48
|
Flurbiprofen 0.03% + HPMC 0.02% + Phenyl mercuric nitrate 0.001% |
Eye Drop |
5ML |
49
|
Gatifloxacin 0.3% w/v , Fluprednate 0.03% w/v, Benzalkonium Chloride Solution IP 0.02% |
Eye Drop |
5 ml |
50
|
Gatifloxacin 0.3% w/v , Loteprednol Etobonate 0.5% w/v, Benzalkonium Chloride Solution IP 0.02% |
Eye Drop |
|
51
|
Gatifloxacin 0.3% w/v , Prednisolone Acetate IP 1% w/v, Benzalkonium Chloride Solution IP 0.02% |
Eye Drop |
5 ml |
52
|
Gatifloxacin 0.5% w/v |
Eye Drop |
|
53
|
Gentamicin Sulphate 0.3% w/v IP \n |
Eye Drop |
|
54
|
Homatropine Hydrobromide IP 2.0%w/v\n |
Eye Drop |
|
55
|
Hydroxypropyl Methylcellulose 0.3% w/v ,Glycerine 0.2%w/v,Dextran-70 0.1%w/v, Stabilized Oxychloro Complex 0.005% w/v\n |
Opthalmic Sol. |
|
56
|
Hydroxypropyl Methylcellulose 2.4 % w/v |
Opthalmic Sol. |
|
57
|
Hypromellose 0.3%w/v, Stabilized Oxychloro Complex 0.0005%w/v\n |
Opthalmic Sol. |
|
58
|
Itraconazole 1%w/v , BenzalkoniumChloride Solution IP 0.02%v/v (As Preservative) |
Opthalmic Susp. |
5ML |
59
|
Ketorolac Tromethamine 0.4% + Hydroxypropylmethylcellulose (HPMC) 0.25% + Benzalkonium Chloride 0.02% |
Eye Drop |
5 ml |
60
|
Ketorolac Tromethamine 0.4% w/v,\nFluorometholone IP (Micronized) 0.1% w/v\nPolyvinyl Alcohol 1.4% w/v\n |
Eye Drop |
5 ml |
61
|
Ketorolac Tromethamine 0.5% w/v, Dexamethasone sodium phosphate 0.01%w/v |
Eye Drop |
|
62
|
Ketorolac Tromethamine 0.5%w/v & Oflaxacin 0.3 %w/v |
Opthalmic Sol. |
5 ML |
63
|
Latanoprost 0.005% w/v |
Eye Drop |
|
64
|
Loteprednol Etabonate 0.2% w/v |
Ophthalmic Susp. |
5 ML |
65
|
Loteprednol Etabonate 0.5 w/v % & Tobramycin 0.3 % w/v |
Opthalmic Sol. |
|
66
|
Loteprednol Etabonate 0.5% w/v |
Opthalmic Sol. |
5 ML |
67
|
Loteprednol Etabonate1% w/v & Levofloxacin Hemihydrate 1% w/v |
Opthalmic Sol. |
|
68
|
Moxifloxacin 0.5% w/v & Ketorolac Tromethamine 0.4% w/v |
Opthalmic Sol. |
5 ML |
69
|
Moxifloxacin 0.5% w/v & Ketorolac Tromethamine 0.4% w/v |
Eye Drop |
5 ml |
70
|
Moxifloxacin 0.5% w/v & Loteprednol Etabonate 0.5 % w/v |
Eye Drop |
5 ml |
71
|
Moxifloxacin 0.5% w/v & Prednisolone 1% w/v |
Eye Drop |
5 ml |
72
|
Moxifloxacin 0.5%w/v |
Eye Drop |
5 ml |
73
|
Moxifloxacin 0.5%w/v ,CarboxyMethylCellulose 0.5%w/v Stabilized Oxychloro Complex 0.005% w/v (as preservative) |
Eye Drop |
5 ml |
74
|
Moxifloxacin 0.5%w/v, Dexamethasone 0.1%w/v & HPMC |
Eye Drop |
5 ml |
75
|
Moxifloxacin Hydrochloride 0.5 % & Bromfenac 0.09% |
Eye Drop |
5 ML |
76
|
Moxifloxacin Hydrochloride 0.5% & Tobramycin Ophthalmic Solution 0.3% |
Eye Drop |
5 ml |
77
|
Naphazoline Hydrochloride 0.1% w/v & Chlorpheniramine Maleate 0.01%w/v |
Opthalmic Sol. |
|
78
|
Naphazoline Hydrochloride 0.05% w/v, Phenylephrine Hydrochloride 0.012%w/v, Menthol 0.005%w/v and Camphor 0.01%w/v with HPMC 0.25% w/v Eye Drops |
Eye Drop |
10 ml |
79
|
Naphazoline Hydrochloride 0.1% w/v USP |
Opthalmic Sol. |
|
80
|
Naphazoline Hydrochloride 0.1% w/v, Chlorpheniramine Maleate 0.01% w/v, Boric Acid 1.25%w/v with HPMC 0.1% w/v Eye Drops |
Eye Drop |
10 ML |
81
|
Natamycin Eye Drops 5 % w/v |
Eye Drop |
5 ml |
82
|
Nepafenac 0.1% w/v (SUSP. BASE & SOLUTION BASE ) |
Eye Drop |
5 ml |
83
|
Ofloxacin 0.3% + Dexamethasone 0.1% |
Eye Drop |
5 ml |
84
|
Ofloxacin 0.3% + Benzalkonium chloride 0.02% |
Eye Drop |
10 ml |
85
|
Ofloxacin 0.3%+ Ketorolac Tromethamine 0.5% + Hydroxypropyl methyl cellulose 0.15%+Benzalkonium, chloride 0.02% |
Eye Drop |
5 ml |
86
|
Olopatadine 0.1% |
Eye Drop |
5 ml |
87
|
Olopatadine 0.1%w/v & Ketorolac 0.4 % w/v Ophthalmic Solution USP |
Opthalmic Sol. |
5 ml |
88
|
Olopatadine Hydrochloride 0.2 % w/v |
Eye Drop |
5 ml |
89
|
Pilocarpine Nitrate IP 2%w/v & Chlorbutol IP 0.5% w/v(As preservative) |
Eye Drop |
|
90
|
Polyethylene Glycol (400) 0.4% w/v & Propylene Glycol 0.3% w/v |
Eye Drop |
10 ml |
91
|
POLYETHYLENE GLYCOL (400) 0.4% w/v & PROPYLENE GLYCOL 0.3% w/v & STABLIZED OXYCHLORO COMPLEX 0.005% w/v |
Eye Drop |
10 ml |
92
|
Polyvinyl Alcohol & Povidone |
Eye Drop |
|
93
|
Potasium Iodide 3.3 %, Sodium Chloride 0.83 %, Calcium Chloride 1 % |
Eye Drop |
10 ml |
94
|
Prednisolone Acetate 1.0% w/v |
Opthalmic Susp. |
|
95
|
Prednisolone Acetate 1.0% w/v, Ofloxacin 0.3% w/v \n |
Opthalmic Susp. |
5 ml |
96
|
Proparacaine Hydrochloride 0.5 % w/v |
Opthalmic Sol. |
|
97
|
Sodium Chloride 0.5% w/v Benzalkonium ChlorideSolution 0.02% v/v |
Opthalmic Sol. |
|
98
|
Sodium Chloride 5.0% w/v Benzalkonium ChlorideSolution 0.02% v/v |
Opthalmic Sol. |
|
99
|
Sodium Hyaluronate 0.1% w/v |
Eye Drop |
10 ml |
100
|
Sodium Hyaluronate 0.18%w/v, Stabilized Oxychloro complex 0.005% w/v |
Eye Drops |
|
101
|
Sodium Hyaluronate 0.2 % w/v And Hydroxypropylmethylcellulose0.2 % w/v |
Eye Drop |
|
102
|
Sulphacetamide Sodium 20% w/v |
Eye Drop |
|
103
|
Sulphacetamide Sodium 15% w/v,Zinc Sulphate 0.1% w/v,Chlorpheniramine Maleate 0.01%w/v,\nBoric Acid 1.9%w/v,Sodium Chloride 0.1%w/v,\nChlorbutol 0.5%w/v\n \n |
Opthalmic Sol. |
10 ML |
104
|
Timolol 0.5 % |
Eye Drop |
5 ml |
105
|
Timolol Maleate 0.5 % w/v & Dorzolamide 2% w/v |
Eye Drop |
5 ml |
106
|
Tobramycin 0.3% w/v & Dexamethasone Sodium Phosphate 0.1% w/v |
Eye Drop |
|
107
|
Tobramycin Sulfate 0.3% w/v & Fluorometholone 0.1% w/v |
Eye Drop |
5 ml |
108
|
Tobramycin USP 0.3% |
Opthalmic Susp. |
5 ML |
109
|
Travoprost 0.004%w/v,Timolol Maleate 0.5% w/v |
Opthalmic Sol. |
|
110
|
Travoprost Eye Drops IP - 0.004% |
Eye Drop |
|
111
|
Tropicamide 0.5% w/v IP |
Eye Drop |
|
112
|
Tropicamide 1% w/v IP |
Eye Drop |
|
113
|
Tropicamide IP 0.8%w/v, Phenylephrine Hydrochloride IP 5.0% w/v, Chlorbutol IP 0.5% w/v |
Eye Drop |
5 ml |
114
|
Trypan Blue 0.6mg,Sodium chloride 8.2mg\n |
Opthalmic Sol. |
|
115
|
Moxifloxacin Hydrochloride 0.5% w/v & Betamethasone Sodium Phosphate 0.1% w/v |
Eye/Ear Drop |
|
116
|
Dexamethasone Sodium Phosphate 0.1%, Neomycin Sulphate 0.5 % , HPMC 0.25 %Eye Drop |
Eye/Ear Drop |
|
117
|
Dexamethasone Sodium Phosphate 0.1%, Neomycin Sulphate 0.5 % Eye Drop |
Eye/Ear Drop |
|
118
|
Ofloxacin 0.3% w/v, Dexamethasone Phosphate 0.1% w/v & Hydroxypropyl-methylcellulose 0.25 %w/v |
Eye/Ear Drop |
|
119
|
Polymyxin B Sulphate 5000 IU,Chloramphenicol 1 mg,Phenylmercuric Nitrate 0.001%w/v \n |
Eye/Ear Drop |
|
120
|
Polymyxin B Sulphate 5000 IU,Chloramphenicol 4 mg,Dexamethasone Sodium Phosphate1 mg,\nPhenylmercuric Nitrate 0.001%w/v |
Eye/Ear Drop |
|